0.830
-0.01 (-0.60%)
| Penutupan Terdahulu | 0.835 |
| Buka | 0.835 |
| Jumlah Dagangan | 22,684 |
| Purata Dagangan (3B) | 1,001,442 |
| Modal Pasaran | 22,904,514 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 31 May 2023 - 15 Jun 2023 |
| Margin Keuntungan | -73.21% |
| Margin Operasi (TTM) | -63.29% |
| EPS Cair (TTM) | -1.39 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -8.30% |
| Nisbah Semasa (MRQ) | 1.01 |
| Aliran Tunai Operasi (OCF TTM) | -31.75 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -22.68 M |
| Pulangan Atas Aset (ROA TTM) | -26.76% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | Centogene N.V. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | NA |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 0.0 |
| Purata | 0.00 |
|
Centogene NV is a United States-based company engaged in data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. The company operates in two segments: pharmaceutical and diagnostics. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its diagnostics segment provides targeted genetic sequencing and diagnostics services to patients. Its geographic regions are Europe, the Middle East, North America, and Latin America. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 4.57% |
| % Dimiliki oleh Institusi | 66.89% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |